Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline

Rheumatology (Oxford). 2001 Feb;40(2):237-9. doi: 10.1093/rheumatology/40.2.237.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / drug therapy*
  • Cabergoline
  • Ergolines / therapeutic use*
  • Female
  • Humans
  • Prolactin / antagonists & inhibitors*
  • Treatment Failure

Substances

  • Ergolines
  • Prolactin
  • Cabergoline